Evidence map›Paper›PMID 30967497›Full record

SynthesisBioscience reports2019

SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.

Haichuan Wang, Hui Cao, Zhong Xu, Dong Wang, Yong Zeng

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Association ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Associations between MICA and MICB Genetic Variants, Protein Levels, and Colorectal Cancer: Atherosclerosis Risk in Communities (ARIC).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Biomarkers for hepatocellular cancer.World journal of hepatology · 2020
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Haichuan WangDepartment of Liver Surgery, Liver Transplantation Division, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-6886-5698
Hui CaoDepartment of Oncology, Guizhou Provincial People's Hospital, Guiyang, China.
Zhong XuDepartment of Gastroenterology, Guizhou Provincial People's Hospital, Guiyang, China.
Dong WangDepartment of Surgery, Transplant and Stem Cell Immunobiology (TSI-) Lab, University of California, San Francisco (UCSF), San Francisco, CA, U.S.A.
Yong ZengDepartment of Liver Surgery, Liver Transplantation Division, West China Hospital, Sichuan University, Chengdu, China zengyong@medmail.com.cn.
Guizhou Provincial People's Hospital · CNSichuan University · CNUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association of major histocompatibility complex class I chain-related gene A (

Indexed as

Polymorphism, Single NucleotideAsian PeopleBlack PeopleCarcinoma, HepatocellularGene FrequencyGenetic Predisposition to DiseaseGenotypeHepacivirusHepatitis CHistocompatibility Antigens Class IHumansLiver NeoplasmsPoint MutationRisk FactorsWhite PeopleHistocompatibility Antigens Class IMHC class I-related chain AHCCMICArs2596542single nucleotide polymorphisms

Identifiers

PMID30967497
PMCPMC6504665
OpenAlexW2940194811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.